Close Menu

NEW YORK (GenomeWeb News) – Complete Genomics today said that it and Illumina have settled two patent infringement lawsuits brought by Illumina.

Illumina will dismiss with prejudice both lawsuits as part of the settlement agreement, and Complete Genomics will dismiss with prejudice all its counterclaims.

The two firms have entered into mutual releases. Each will be responsible for its own legal costs, and no payment was made by either party to the other. No licenses are being granted, either.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.